Caption Management, LLC Crispr Therapeutics Ag Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $12.8 Million - $17 Million	-250,000 Reduced 64.94%	135,000 $7.29 Million
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $11.9 Million - $17.4 Million	-195,700 Reduced 33.7%	385,000 $26.2 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $18.7 Million - $34.9 Million	483,400 Added 496.81%	580,700 $36.4 Million
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $2.86 Million - $3.72 Million	-63,000 Reduced 39.3%	97,300 $4.42 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $6.97 Million - $10.9 Million	160,300 New	160,300 $9 Million
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $1.57 Million - $2.63 Million	-40,000 Reduced 61.54%	25,000 $1.02 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $305,500 - $418,900	5,000 Added 8.33%	65,000 $4.25 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $1.73 Million - $2.95 Million	40,000 Added 200.0%	60,000 $3.65 Million
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $265,950 - $396,200	5,000 Added 33.33%	20,000 $1.26 Million
Q4 2021 Feb 11, 2022	BUY	$70.09 - $111.29 $1.05 Million - $1.67 Million	15,000 New	15,000 $1.14 Million
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $4.4 Million - $6.25 Million	-39,900 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $262,184 - $420,913	-2,600 Reduced 6.12%	39,900 $6.46 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $4.71 Million - $8.93 Million	42,500 New	42,500 $5.18 Million
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $3.53 Million - $4.53 Million	-45,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $2.12 Million - $4.18 Million	-55,000 Reduced 55.0%	45,000 $3.31 Million
Q4 2019 Feb 13, 2020	BUY	$36.68 - $73.13 $3.67 Million - $7.31 Million	100,000 New	100,000 $6.09 Million
Q4 2018 Jan 30, 2019	SELL	$22.73 - $42.34 $213,662 - $397,996	-9,400 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$42.62 - $73.59 $400,628 - $691,746	9,400 New	9,400 $553,000

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$367 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$347 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$139 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$137 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$137 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account